Clinical Trial 41494

share

Decatur, GA 30033


Study Summary:

The primary objective of the study is to evaluate the efficacy of AGB101 on slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with mild cognitive impairment due to Alzheimer's Disease (MCI due to AD) also known as prodromal AD. 


Qualified Participants Must:

• Have memory loss
• Between ages of 55-85
• Have availability of a study partner


Qualified Participants May Receive:

May receive compensation for time and travel.


Study is Available At:

NeuroStudies
2665 N. Decatur Rd.
Suite 740
Decatur, GA 30033
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 100 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.